Evidence based public longevity infrastructure programs for governments.
A government longevity programme is evidence-based when the programme itself, at scale, has changed outcomes. Tobacco control has decades of proof; organised screening and vaccination programmes with reminder systems have trial and programme evidence; blood-pressure control programmes with registries have raised control rates and cut strokes; falls-prevention exercise and hearing services have excellent trial evidence but almost no programme evidence because few governments have delivered them; diabetes-prevention programmes, alcohol minimum pricing, active-travel infrastructure and social prescribing follow. Longevity institutes, national wellness apps, brain-training and companion-robot schemes have been funded and evaluated to nothing.
A public longevity programme is evidence-based when the programme itself, delivered at scale, has been shown to change an outcome that matters — not when the intervention inside it worked in a trial that the programme then failed to deliver — and the ranking below grades programmes on that tier of evidence. First: comprehensive tobacco control (taxation, smoke-free law, plain packaging, cessation services), with natural experiments across decades and countries showing falls in cardiovascular events, respiratory admissions, cancers and deaths. Second: organised screening and vaccination programmes with registries and call-recall — colorectal, breast and cervical screening within guideline ages, adult vaccination — with randomised evidence for the interventions and programme-level evidence for coverage and mortality. Third: hypertension control programmes with registries and protocol titration, with system-level evidence (Canadian and integrated-system programmes) of control rates rising from a third to two-thirds and stroke falling. Fourth: falls-prevention exercise and hearing services, with high-certainty trial evidence and — the tier that separates them from the rows above — little programme-level evidence, because few governments have delivered them at scale. Fifth: diabetes-prevention programmes, with randomised evidence for the intervention and pragmatic programme evidence for weight and progression at scale. Sixth: alcohol minimum unit pricing, with real-world evidence of reduced alcohol-specific deaths. Seventh: active-travel and clean-air infrastructure, with natural-experiment evidence. Eighth: social prescribing, promising with maturing evaluation. Last, without programme evidence: longevity institutes, national biological-age or wellness-app schemes, brain-training and companion-robot programmes, which governments have funded and evaluations have found wanting.
- Evidence-based applies to the programme at scale, not just the intervention in a trial.
- Tobacco control and organised screening and vaccination have decades of programme evidence.
- Falls prevention and hearing have the best trial evidence and almost no programme evidence, because almost no government has delivered them.
- Hypertension control programmes have shown what a registry and a protocol can do to stroke rates.
- Institutes, apps, brain-training and robots are funded without evidence and evaluated to nothing.
Programmes ranked by evidence tier
Ranked on: the highest tier of evidence available for the programme as delivered at scale — natural experiments across jurisdictions, programme-level outcome data, randomised evidence for the intervention only, or none — and the consistency of that evidence.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Comprehensive tobacco control | Natural experiments across decades and countries | GRADE AEstablished |
| 2 | Organised screening and vaccination programmes with registries and call-recall | Randomised evidence for the interventions; programme evidence for coverage and mortality | GRADE AEstablished |
| 3 | Hypertension control programmes | System-level evidence of control rising and stroke falling | GRADE AEstablished |
| 4 | Falls-prevention exercise and hearing services | High-certainty trial evidence; little programme evidence, because few have delivered | GRADE BPromising |
| 5 | Diabetes-prevention programmes | Randomised intervention evidence; pragmatic programme evidence at scale | GRADE BPromising |
| 6 | Alcohol minimum unit pricing | Real-world evidence of reduced alcohol-specific deaths | GRADE BPromising |
| 7 | Active-travel and clean-air infrastructure | Natural-experiment evidence; long horizons | GRADE BPromising |
| 8 | Social prescribing | Promising; evaluation maturing | GRADE CEarly |
| 9 | Longevity institutes, national wellness apps, brain-training, companion-robot and device schemes | Funded without evidence; evaluated to nothing | GRADE DInsufficient or unsafe |
- 01
Comprehensive tobacco control
GRADE AEstablishedNatural experiments across decades and countriesTaxation, smoke-free legislation, plain packaging, advertising bans and cessation services, evaluated across dozens of jurisdictions: falls in smoking prevalence, acute coronary events, respiratory admissions, cancers and deaths, with the largest gains in the poorest groups. The deepest programme-level evidence base in public health.
- 02
Organised screening and vaccination programmes with registries and call-recall
GRADE AEstablishedRandomised evidence for the interventions; programme evidence for coverage and mortalityColorectal, breast and cervical screening within guideline ages, and adult vaccination, delivered through population registries with automated invitation and pharmacy or community delivery. Programme evaluations show mortality reductions tracking coverage; randomised trials of outreach show coverage can be raised. The programme is the registry and the invitation.
- 03
Hypertension control programmes
GRADE AEstablishedSystem-level evidence of control rising and stroke fallingNational and integrated-system programmes with registries, treatment protocols, pharmacist- and nurse-led titration and a target control rate. Canada's national programme and large integrated US systems raised control from about a third to over two-thirds and recorded falls in stroke. Reproducible where the registry and protocol are built.
- 04
Falls-prevention exercise and hearing services
GRADE BPromisingHigh-certainty trial evidence; little programme evidence, because few have deliveredBalance and functional exercise (23% fewer falls, 108 RCTs, high certainty) and hearing-aid provision (27% fewer falls over three years). The intervention evidence is the best in ageing; programme-level evidence is thin because national delivery at scale is rare, and fall deaths have risen meanwhile. The programme that delivered these at scale would move to tier one.
- 05
Diabetes-prevention programmes
GRADE BPromisingRandomised intervention evidence; pragmatic programme evidence at scaleStructured lifestyle programmes for people with prediabetes, with randomised trials showing reduced progression and national programmes (England's NHS DPP, US CDC-recognised DPPs) reporting weight loss and reduced progression in pragmatic evaluations. Evidence that a behaviour programme can be run at national scale.
- 06
Alcohol minimum unit pricing
GRADE BPromisingReal-world evidence of reduced alcohol-specific deathsScotland's minimum unit price evaluation reported reductions in alcohol-specific deaths and hospital admissions, concentrated in the most deprived groups. A single policy with a controlled evaluation; more jurisdictions are adopting it.
- 07
Active-travel and clean-air infrastructure
GRADE BPromisingNatural-experiment evidence; long horizonsCycling and walking infrastructure, low-emission zones and air-quality regulation, with natural-experiment evidence for physical activity, respiratory and cardiovascular outcomes. Effects accrue over years and the designs are observational; consistently positive.
- 08
Social prescribing
GRADE CEarlyPromising; evaluation maturingLink workers connecting people to community activity, befriending and support. Wellbeing and function gains in evaluations; outcome and cost-effectiveness evidence still accumulating. Fund with evaluation designed in.
- 09
Longevity institutes, national wellness apps, brain-training, companion-robot and device schemes
GRADE DInsufficient or unsafeFunded without evidence; evaluated to nothingFlagship longevity institutes have no population outcome; national wellness or biological-age apps have download figures; brain-training programmes show no transfer to daily function and no cleared digital therapeutic exists for cognition in older adults; the PARO companion robot matched a switched-off plush toy; no fall-detection device is cleared. Governments have funded each; none has evidence as a programme.
The evidence tiers, and what moves a programme up
Evidence tiers for public longevity programmes
| Tier | What it means | Programmes at this tier | What moves a programme up |
|---|---|---|---|
| Programme evidence across jurisdictions | The programme at scale changed outcomes in multiple countries | Tobacco control; organised screening and vaccination | — |
| Programme evidence in one or few systems | A national or system-level programme changed outcomes | Hypertension control; diabetes prevention; minimum unit pricing | Replication |
| Intervention evidence only | Trials show the intervention works; the programme has not been delivered at scale | Falls-prevention exercise; hearing services; cataract access; deprescribing | Delivery at scale with randomised rollout |
| Observational and natural-experiment evidence | Consistent associations and before-after designs with controls | Active travel; clean air; age-friendly environment | Better designs; longer follow-up |
| Promising | Early evaluations positive; outcomes and costs immature | Social prescribing | Pre-registered evaluation |
| No programme evidence | Funded; no outcome, or trials null | Institutes; apps; brain-training; robots; device schemes | Evidence, before funding |
Frequently asked questions
What are the evidence-based public longevity infrastructure programmes for governments?
Ranked by evidence tier: comprehensive tobacco control; organised screening and vaccination programmes with registries and call-recall; hypertension control programmes; falls-prevention exercise and hearing services (high-certainty trial evidence, little programme evidence); diabetes-prevention programmes; alcohol minimum unit pricing; active-travel and clean-air infrastructure; social prescribing; and, without evidence, longevity institutes, wellness apps, brain-training and companion-robot schemes.
What is the difference between intervention evidence and programme evidence?
Intervention evidence shows something works in a trial — a balance class cuts falls by 23%. Programme evidence shows that a government delivering it at scale changed the population's outcomes. Falls prevention has excellent intervention evidence and almost no programme evidence, because few governments have delivered it; tobacco control has both. Governments should fund on intervention evidence and evaluate to produce programme evidence.
Which programme has the strongest evidence?
Comprehensive tobacco control: taxation, smoke-free law, plain packaging and cessation services, evaluated across dozens of jurisdictions over decades, with falls in smoking, cardiovascular events, respiratory admissions, cancers and deaths, largest among the poorest. No other longevity programme has evidence of that depth.
Do hypertension control programmes work at national scale?
Yes, where a registry, treatment protocol and pharmacist- or nurse-led titration are built: Canada's national programme and large integrated US systems raised control from about a third of hypertensives to over two-thirds and recorded falls in stroke. Most countries remain below half, so the programme evidence exists and the delivery does not.
Is there evidence for national diabetes-prevention programmes?
Yes. Randomised trials show structured lifestyle programmes reduce progression from prediabetes to diabetes, and national programmes — England's NHS Diabetes Prevention Programme and CDC-recognised programmes in the US — report weight loss and reduced progression in pragmatic evaluations at scale. They are the clearest evidence that a behaviour-change programme can be run nationally.
Which programmes do governments fund without evidence?
Flagship longevity institutes (no population outcome), national wellness or biological-age apps (download figures, no outcomes), brain-training programmes (no transfer to daily function; no cleared digital therapeutic for cognition in older adults), companion-robot schemes (PARO matched a switched-off plush toy), and fall-detection device schemes (no cleared device, no outcome evidence). Each has been funded somewhere; none has programme evidence.
Keep reading
- Public health and policy
The programme records and the country cases.
- Longevity technology
The trial evidence for falls, hearing, cataract and robots.
- How to evaluate impact of public longevity infrastructure?
How to generate programme evidence.
- How we grade evidence
The grading behind the tiers.
More in Public health & policy
- What is public longevity infrastructure and why it matters?
Public longevity infrastructure defined — the laws, budgets, services and built environment a government uses to extend healthy life — and its components ranked by evidence: tobacco and alcohol policy, vaccination and screening delivery, hypertension control, primary and pharmacy care, air quality and active-travel design, falls prevention, and longevity research — with why the morbidity gap makes it matter now.
- How to invest in public longevity infrastructure projects?
How private capital can invest in public longevity infrastructure, ranked by instrument and project type: municipal and sovereign health bonds, social and health impact bonds, public-private partnerships for primary-care and diagnostic facilities, listed healthcare-infrastructure and REIT exposure, and impact funds — with what returns are realistic, what 'longevity dividend' figures actually mean, and the questions to ask before committing.
- Which public longevity infrastructure solutions offer best ROI?
Public longevity infrastructure solutions ranked on return per healthy life-year with the evidence caveats stated: tobacco and alcohol taxation, salt and sugar policy, vaccination delivery, hypertension control, cessation services, falls-prevention exercise, screening programmes, active-travel infrastructure, and longevity clinics or research institutes — with why ROI figures vary from negative to 30:1 and what a treasury should actually expect.
- How can governments fund public longevity infrastructure effectively?
Funding mechanisms for public longevity infrastructure ranked on whether money reaches delivery and survives budget cycles: earmarked health taxes, legally reserved prevention shares (EU4Health's 20%), ring-fenced prevention budgets, outcome-linked payments, general taxation with performance frameworks, and one-off capital programmes — with the evidence from the EU, UK and Singapore on what holds and what evaporates.
- What public longevity infrastructure strategies improve population health outcomes?
Public longevity strategies ranked on recorded population-health outcomes: fiscal and regulatory control of tobacco, alcohol and diet; universal primary care with enrolment (Singapore's Healthier SG model); organised vaccination and screening with call-recall; hypertension control at scale; deprivation-targeted delivery to close the 20-year healthy-life gap; healthy-ageing services; and target-led strategies without delivery — with what each has actually changed.
- How to evaluate impact of public longevity infrastructure?
A ranked method for evaluating public longevity infrastructure: pick outcomes that matter (healthy life expectancy by deprivation, morbidity gap), use designs that can attribute (randomised rollouts, stepped-wedge, difference-in-differences, synthetic controls), track delivery and coverage first, measure equity, model cost-effectiveness honestly, and avoid the evaluation traps that let target-led strategies claim success.